INFI - Infinity Pharmaceuticals Inc. (INFI) CEO Adelene Perkins on Q4 2018 Results - Earnings Call Transcript
Infinity Pharmaceuticals Inc. (INFI)
Q4 2018 Results Earnings Conference Call
March 14, 2019 08:00 AM ET
Company Participants
Jayne Kauffman - Senior Executive Coordinator
Adelene Perkins - CEO
Samuel Agresta - CMO
Lawrence Bloch - President
Jeffery Kutok - Chief Scientific Officer
Conference Call Participants
Katherine Xu - William Blair
Tessa Romero - JP Morgan
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the Company's Financial Results for the Full Year 2018. My name is Candice, and I'll be your operator for today's call.